Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 4/20 | 0.37 |
| ▸ | GABRP | O00591 | 3/20 | 0.32 |
| ▸ | GABRD | O14764 | 3/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.32 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.32 |
| ▸ | GABRA4 | P48169 | 3/20 | 0.32 |
| ▸ | GABRE | P78334 | 3/20 | 0.32 |
| ▸ | GABRA6 | Q16445 | 3/20 | 0.32 |
| ▸ | GABRG1 | Q8N1C3 | 3/20 | 0.32 |
| ▸ | GABRG3 | Q99928 | 3/20 | 0.32 |
| ▸ | GABRQ | Q9UN88 | 3/20 | 0.32 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.32 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27893185 | 0.98 | GABRR1 (0.35) | GABRR1GABRPGABRDGABRA1GABRB1 | |
| Methacrylic Acid SCHEMBL6561456 | 0.91 | GABRR1 (0.31) | GABRR1 | |
| SCHEMBL11112222 | 0.88 | GABRR1 (0.43) | GABRR1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL11767532 | 0.86 | — | — | |
| SCHEMBL18986068 | 0.80 | HDAC1 (0.40) | HDAC3THRBTSHRHDAC1HDAC2 | |
| SCHEMBL27838004 | 0.78 | — | — | |
| SCHEMBL6668764 | 0.77 | CAMK2A (0.41) | — | |
| SCHEMBL9322240 | 0.75 | ALDH1A1 (0.36) | — | |
| SCHEMBL7857868 | 0.72 | PAOX (0.37) | GABRR1GABRPGABRDGABRA1GABRB1 | |
| Hydrochloric Acid SCHEMBL7120514 | 0.71 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0900563-B1 | Production of pharmaceutical formulations containing aescin for treatment of edema and venous disorders | KLINGE CO CHEM PHARM FAB (DE) | 2004-02-11 | — | — | EP | claimed |
| WO-1999030685-A1 | POLYMERIC MICROPOROUS FILM COATED SUBCUTANEOUS IMPLANTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-06-24 | — | — | WO | claimed |
| EP-3487916-B1 | FUNCTIONALIZED PARTICULATE BICARBONATE AS BLOWING AGENT, FOAMABLE POLYMER COMPOSITION CONTAINING IT, AND ITS USE IN MANUFACTURING A THERMOPLASTIC FOAMED POLYMER | SOLVAY (BE) | 2025-09-03 | — | — | EP | disclosed |
| US-12116467-B2 | Foamable crosslinkable polymer composition containing a functionalized particulate bicarbonate as blowing agent and method for manufacturing a crosslinked foamed polymer therefrom | SOLVAY SA (BE) | 2024-10-15 | — | — | US | disclosed |
| EP-3655469-B1 | FUNCTIONALIZED PARTICULATE BICARBONATE AS BLOWING AGENT, FOAMABLE POLYMER COMPOSITION CONTAINING IT, AND ITS USE IN MANUFACTURING A THERMOPLASTIC FOAMED POLYMER | SOLVAY (BE) | 2024-09-25 | — | — | EP | disclosed |
| US-20240239980-A1 | FUNCTIONALIZED PARTICULATE BICARBONATE AS BLOWING AGENT, FOAMABLE POLYMER COMPOSITION CONTAINING IT, AND ITS USE IN MANUFACTURING A THERMOPLASTIC FOAMED POLYMER | SOLVAY SA (BE) | 2024-07-18 | — | — | US | disclosed |
| US-11926722-B2 | Functionalized particulate bicarbonate as blowing agent, foamable polymer composition containing it, and its use in manufacturing a thermoplastic foamed polymer | SOLVAY SA (BE) | 2024-03-12 | — | — | US | disclosed |
| EP-3655470-B1 | FUNCTIONALIZED PARTICULATE BICARBONATE AS BLOWING AGENT, FOAMABLE POLYMER COMPOSITION CONTAINING IT, AND ITS USE IN MANUFACTURING A THERMOPLASTIC FOAMED POLYMER | SOLVAY (BE) | 2023-09-20 | — | — | EP | disclosed |
| US-11421094-B2 | Functionalized particulate bicarbonate as blowing agent, foamable polymer composition containing it, and its use in manufacturing a thermoplastic foamed polymer | SOLVAY SA (BE) | 2022-08-23 | — | — | US | disclosed |
| US-20220259396-A1 | FUNCTIONALIZED PARTICULATE BICARBONATE AS BLOWING AGENT, FOAMABLE POLYMER COMPOSITON CONTAINING IT, AND ITS USE IN MANUFACTURING A THERMOPLASTIC FOAMED POLYMER | SOLVAY SA (BE) | 2022-08-18 | — | — | US | disclosed |
| US-20220175351-A1 | Devices and Methods for Collecting Gastrointestinal Samples | ENVIVO BIO INC. (US) | 2022-06-09 | — | — | US | disclosed |
| US-20110002906-A1 | Purification and Isolation of Recombinant Oxalate Degrading Enzymes and Spray-Dried Particles Containing Oxalate Degrading Enzymes | OXTHERA INTELLECTUAL PROPERTY AB (SE) | 2011-01-06 | — | — | US | disclosed |
| WO-2011000523-A1 | PURIFICATION AND ISOLATION OF RECOMBINANT OXALATE DEGRADING ENZYMES AND SPRAY-DRIED PARTICLES CONTAINING OXALATE DEGRADING ENZYMES | OXTHERA INTELLECTUAL PROPERTY AB (SE) | 2011-01-06 | — | — | WO | disclosed |
| WO-2010102218-A1 | COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING | MITHRIDION, INC. (US) | 2010-09-10 | — | — | WO | disclosed |
| EP-2153834-A2 | Extended release pharmaceutical compositions comprising quetiapine salts | Farmaprojects, S.A. (ES) | 2010-02-17 | — | — | EP | disclosed |
| US-20090324716-A1 | Coated Particles Containing Pharmaceutically Active Agents | JOHNSON & JOHNSON CONSUMER INC. | 2009-12-31 | — | — | US | disclosed |
| WO-2009158368-A1 | COATED PARTICLES CONTAINING PHARMACEUTICALLY ACTIVE AGENTS | MCNEIL-PPC, INC. (US) | 2009-12-30 | — | — | WO | disclosed |
| EP-1838291-A4 | PHARMACEUTICAL FORMULATIONS AND METHODS OF USE | PHARMANOVA INC (US) | 2008-12-03 | — | — | EP | disclosed |
| EP-1838291-A2 | PHARMACEUTICAL FORMULATIONS AND METHODS OF USE | Pharmanova Inc. (US) | 2007-10-03 | — | — | EP | disclosed |
| WO-2006078811-A2 | PHARMACEUTICAL FORMULATIONS AND METHODS OF USE | PHARMANOVA INC. (US) | 2006-07-27 | — | — | WO | disclosed |